Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-12

Clinical Trial Update: Evaluating the Efficacy of Dry Eye (DE) Disease Treatment Using Novel Tear Film Imager (TFI) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating a novel Tear Film Imager for dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tear Film Imager

Snippet

Sponsor: Adom Advanced Optical Technologies Ltd. | Conditions: Dry Eye Disease | Phase 2, Phase 3 | Status: COMPLETED